Lymphatic Filariasis Treatment Market By Treatment Type (Pharmacological {Anthelmintics, Antibiotics, Anti-inflammatory Drugs}, Surgical Treatment {Hydrocele Surgery, Lymphatic Shunt Procedures}, Supportive Care), By Route of Administration (Oral, Injectable, Topical, Other), By End-User (Hospitals and Clinics, Homecare Settings, Research, and Academic Institutions), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Published Date: Dec 2024 | Report ID: MI1498 | 225 Pages

Report Summary Table of Contents Segmentation FAQ Request Free Sample Report

Report Coverage:

By Treatment Type

  • Pharmacological
    • Anthelmintics
    • Antibiotics
    • Anti-inflammatory Drugs
  • Surgical Treatment
    • Hydrocele Surgery
    • Lymphatic Shunt Procedures
  • Supportive Care

 By Route of Administration

  • Oral
  • Injectable
  • Topical
  • Other

By End-User

  • Hospitals and Clinics
  • Homecare Settings
  • Research and Academic Institutions

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of the Middle East & Africa

List of Companies:

  • Merck & Co.
  • GlaxoSmithKline
  • Johnson & Johnson
  • AbbVie Inc.
  • Eisai Co., Ltd.
  • Anacor Pharmaceuticals
  • Cipla
  • Sanofi
  • Pfizer Inc.
  • Boehringer Ingelheim
  • Atra Pharmaceuticals
  • Unimark Remedies
  • K.A. Malle Pharmaceuticals
  • Dr. Reddy's Laboratories
  • Novartis
  • Sun Pharmaceutical Industries Ltd.
  • Zydus Cadila
  • Mylan N.V.

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.

Request Bundle Pricing